Max Robotics — Global Service Robot Directory + US Certification

About

Leif-Hendrik Boldt is a cardiologist and clinical researcher whose work sits at the dynamic intersection of cardiac electrophysiology, interventional cardiology, and emerging therapeutic technologies. His research has made meaningful contributions to the treatment of complex cardiac arrhythmias, with a particular focus on atrial fibrillation (AF) and ventricular tachycardia (VT). Boldt has been a notable contributor to the advancement of robotic catheter ablation for AF, exploring how remote catheter systems can enhance the precision and safety of pulmonary vein isolation — a cornerstone procedure for rhythm control in AF patients. His publications in this area, accumulating over 30 citations, helped characterize the clinical utility and technical nuances of robotic ablation platforms in real-world practice. More recently, Boldt has extended his expertise into the frontier field of cardiac radioablation, contributing to the multicenter RAVENTA trial — an ambitious benchmarking initiative evaluating stereotactic radiotherapy for ventricular tachycardia. This work reflects a broader vision of integrating radiation oncology principles into cardiology, a rapidly evolving discipline. Across his career, Boldt exemplifies the clinician-researcher committed to translating technological innovation into improved patient outcomes for some of the most challenging cardiac conditions.